PubMed:27028795 / 0-164 JSONTXT

{"project":"Preeclampsia","denotations":[{"id":"PD-Preeclampsia-B_T1","span":{"begin":55,"end":67},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.\nOBJECTIVE: To evaluate KRYPTOR assays for circulating soluble fms-like"}

{"project":"Preeclampsia-compare","denotations":[{"id":"PD-Preeclampsia-B_T1","span":{"begin":55,"end":67},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.\nOBJECTIVE: To evaluate KRYPTOR assays for circulating soluble fms-like"}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":93},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":94,"end":104},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":93},"obj":"Sentence"},{"id":"T2","span":{"begin":94,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.\nOBJECTIVE: To evaluate KRYPTOR assays for circulating soluble fms-like"}